Rufinamide Suspension
Product Images NDC 68180-797

16 FDA label images from Lupin Pharmaceuticals, Inc. · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 16 technical images submitted to the FDA as part of the official labeling for Rufinamide (NDC 68180-797). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Lupin Pharmaceuticals, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Description (47c9752b A06d 46af A029 9213e2474378 01)

Description (47c9752b A06d 46af A029 9213e2474378 01)
Chemical structure of the active ingredient Rufinamide, depicting its molecular composition and bonding arrangement.*
FDA Label Image

Trade Mark (47c9752b A06d 46af A029 9213e2474378 02)

FDA Label Image

Trade Mark (47c9752b A06d 46af A029 9213e2474378 03)

FDA Label Image

Image (47c9752b A06d 46af A029 9213e2474378 04)

Image (47c9752b A06d 46af A029 9213e2474378 04)
An instructional illustration showing packaging components for Rufinamide oral suspension 40 mg/mL by Lupin Pharmaceuticals, Inc. It depicts a bottle, a box, a bottle adapter, and two syringes used for dosing the medication.*
FDA Label Image

B (47c9752b A06d 46af A029 9213e2474378 05)

B (47c9752b A06d 46af A029 9213e2474378 05)
An instructional illustration showing a hand holding a bottle with an arrow indicating to shake the bottle well. The text 'Shake well' is displayed to emphasize the instruction, relevant for oral suspension products like Rufinamide 40 mg/mL.*
FDA Label Image

C (47c9752b A06d 46af A029 9213e2474378 06)

C (47c9752b A06d 46af A029 9213e2474378 06)
An illustration showing a bottle adapter component, labeled clearly with the text 'bottle adapter.' This is a line drawing highlighting the shape and labeling of the part.*
FDA Label Image

D (47c9752b A06d 46af A029 9213e2474378 07)

D (47c9752b A06d 46af A029 9213e2474378 07)
An instructional illustration showing a hand holding the neck of a bottle and an arrow pointing downward, indicating the action to push down, likely demonstrating how to open or close the bottle cap for the Rufinamide oral suspension.*
FDA Label Image

Image (47c9752b A06d 46af A029 9213e2474378 08)

Image (47c9752b A06d 46af A029 9213e2474378 08)
An illustrated diagram of an oral dosing syringe with a labeled plunger and a close-up inset showing measurement markings from 13 to 19 mL, highlighting the 15 mL mark. The syringe is designed for measuring liquid medication doses accurately.*
FDA Label Image

Image (47c9752b A06d 46af A029 9213e2474378 09)

Image (47c9752b A06d 46af A029 9213e2474378 09)
An instructional illustration showing a hand holding an oral dosing syringe, positioned to insert the syringe tip into the neck of a medicine bottle, with a large arrow indicating the downward motion.*
FDA Label Image

Image (47c9752b A06d 46af A029 9213e2474378 10)

Image (47c9752b A06d 46af A029 9213e2474378 10)
An instructional illustration showing a hand holding a dosing syringe filled with a liquid medication, with volume markings from 0 to 20 mL. An arrow points downward, indicating how to push the plunger to administer or measure the medication. This image is likely related to the use or dosing of Rufinamide oral suspension.*
FDA Label Image

Image (47c9752b A06d 46af A029 9213e2474378 11)

Image (47c9752b A06d 46af A029 9213e2474378 11)
An instructional illustration showing how to measure Rufinamide oral suspension using a syringe. The image highlights filling the syringe to the indicated mark, specifying to measure to the yellow end of the plunger for accurate dosing.*
FDA Label Image

Image (47c9752b A06d 46af A029 9213e2474378 12)

Image (47c9752b A06d 46af A029 9213e2474378 12)
An instructional illustration showing an adult or caregiver administering oral suspension medicine to a child using an oral syringe. The syringe is positioned near the child's mouth for dosing.*
FDA Label Image

Image (47c9752b A06d 46af A029 9213e2474378 13)

Image (47c9752b A06d 46af A029 9213e2474378 13)
An instructional illustration showing how to measure and administer Rufinamide oral suspension using a syringe. The left side shows drawing liquid into the syringe from a cup, while the right side shows dispensing the suspension from the syringe by pressing down the plunger.*
FDA Label Image

Image (47c9752b A06d 46af A029 9213e2474378 14)

Image (47c9752b A06d 46af A029 9213e2474378 14)
An instructional line drawing showing a hand gripping the cap of a bottle, demonstrating how to open the bottle by twisting the cap. The bottle appears to be a suspension dosage form, consistent with oral liquid medication like Rufinamide suspension.*
FDA Label Image

Label (47c9752b A06d 46af A029 9213e2474378 15)

Label (47c9752b A06d 46af A029 9213e2474378 15)
Label for Rufinamide Oral Suspension 40 mg/mL, an oral suspension in a 460 mL bottle by Lupin Pharmaceuticals, Inc. The label includes dosage strength, pharmacist dispensing instructions, storage recommendations, and manufacturer details including Lupin Pharmaceuticals and Hetero Labs Limited. It features a barcode and a QR code for accessing the medication guide.*
FDA Label Image

Carton Label (47c9752b A06d 46af A029 9213e2474378 16)

Carton Label (47c9752b A06d 46af A029 9213e2474378 16)
The packaging label for Rufinamide Oral Suspension 40 mg/mL, an oral suspension in a 460 mL size by Lupin Pharmaceuticals, Inc. The label includes administration instructions, storage conditions, dosage guidance, and manufacturing details by Lupin Pharmaceuticals, Inc. in the USA and Hetero Labs Limited in India. The product is orange flavored, Rx only, and supplied with two 20 mL syringes for administration.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.